D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Tax Provision Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Tax Provision
-myr11.1m
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
-2%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Tax Provision
-myr1.4m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
-4%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Tax Provision
-myr25.4m
CAGR 3-Years
-22%
CAGR 5-Years
-21%
CAGR 10-Years
-9%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Tax Provision
-myr6.7m
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Tax Provision
-myr16.9m
CAGR 3-Years
-43%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
K
Kotra Industries Bhd
KLSE:KOTRA
Tax Provision
-myr11.9m
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
-60%

See Also

What is Duopharma Biotech Bhd's Tax Provision?
Tax Provision
-11.1m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Tax Provision amounts to -11.1m MYR.

What is Duopharma Biotech Bhd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-2%

Over the last year, the Tax Provision growth was 14%. The average annual Tax Provision growth rates for Duopharma Biotech Bhd have been 16% over the past three years , 7% over the past five years , and -2% over the past ten years .

Back to Top